PMC:7736111 / 4360-4573 JSONTXT

{"project":"LitCovid-PD-HP","denotations":[{"id":"T5","span":{"begin":24,"end":49},"obj":"Phenotype"},{"id":"T6","span":{"begin":55,"end":70},"obj":"Phenotype"}],"attributes":[{"id":"A5","pred":"hp_id","subj":"T5","obj":"http://purl.obolibrary.org/obo/HP_0033041"},{"id":"A6","pred":"hp_id","subj":"T6","obj":"http://purl.obolibrary.org/obo/HP_0001888"}],"text":"innate immune cells and cytokine release syndrome) and lymphocytopenia (reduced levels of CD4+, CD8+, and B cells) (Gibson et al., 2020). These changes are followed by cell death and tissue destruction, which ulti"}

{"project":"LitCovid-PubTator","denotations":[{"id":"65","span":{"begin":90,"end":93},"obj":"Gene"},{"id":"66","span":{"begin":96,"end":99},"obj":"Gene"},{"id":"89","span":{"begin":55,"end":70},"obj":"Disease"}],"attributes":[{"id":"A65","pred":"tao:has_database_id","subj":"65","obj":"Gene:920"},{"id":"A66","pred":"tao:has_database_id","subj":"66","obj":"Gene:925"},{"id":"A89","pred":"tao:has_database_id","subj":"89","obj":"MESH:D008231"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"innate immune cells and cytokine release syndrome) and lymphocytopenia (reduced levels of CD4+, CD8+, and B cells) (Gibson et al., 2020). These changes are followed by cell death and tissue destruction, which ulti"}